These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32178745)

  • 1. Systematic review of gene expression studies in people with Lewy body dementia.
    Chowdhury A; Rajkumar AP
    Acta Neuropsychiatr; 2020 Dec; 32(6):281-292. PubMed ID: 32178745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of genetic association studies in people with Lewy body dementia.
    Sanghvi H; Singh R; Morrin H; Rajkumar AP
    Int J Geriatr Psychiatry; 2020 May; 35(5):436-448. PubMed ID: 31898332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmortem Cortical Transcriptomics of Lewy Body Dementia Reveal Mitochondrial Dysfunction and Lack of Neuroinflammation.
    Rajkumar AP; Bidkhori G; Shoaie S; Clarke E; Morrin H; Hye A; Williams G; Ballard C; Francis P; Aarsland D
    Am J Geriatr Psychiatry; 2020 Jan; 28(1):75-86. PubMed ID: 31327631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INDEL Length and Haplotypes in the β-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies?
    Gámez-Valero A; Canet-Pons J; Urbizu A; Anillo A; Santos C; Ariza A; Beyer K
    J Alzheimers Dis; 2018; 65(1):207-219. PubMed ID: 30040713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease.
    Hou X; Fiesel FC; Truban D; Castanedes Casey M; Lin WL; Soto AI; Tacik P; Rousseau LG; Diehl NN; Heckman MG; Lorenzo-Betancor O; Ferrer I; Arbelo JM; Steele JC; Farrer MJ; Cornejo-Olivas M; Torres L; Mata IF; Graff-Radford NR; Wszolek ZK; Ross OA; Murray ME; Dickson DW; Springer W
    Autophagy; 2018; 14(8):1404-1418. PubMed ID: 29947276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional Overlap of Pathologies in Lewy Body Disorders.
    Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
    J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M; Gelpi E; Martí MJ; Compta Y
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression.
    Sorrentino ZA; Goodwin MS; Riffe CJ; Dhillon JS; Xia Y; Gorion KM; Vijayaraghavan N; McFarland KN; Golbe LI; Yachnis AT; Giasson BI
    Acta Neuropathol Commun; 2019 Sep; 7(1):142. PubMed ID: 31477175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of beta-synuclein in cortical neurons is associated with autophagy attenuation in the brains of dementia with Lewy body patients.
    Evans T; Kok WL; Cowan K; Hefford M; Anichtchik O
    Brain Res; 2018 Feb; 1681():1-13. PubMed ID: 29278715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel C. elegans models of Lewy body disease reveal pathological protein interactions and widespread miRNA dysregulation.
    Li R; Huang X; Shen L; Zhang T; Liu N; Hou X; Wong G
    Cell Mol Life Sci; 2024 Aug; 81(1):377. PubMed ID: 39212733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation changes and aberrant expression of FGFR3 in Lewy body disease neurons.
    Tsuchida T; Mano T; Koshi-Mano K; Bannai T; Matsubara T; Yamashita S; Ushijima T; Nagata K; Murayama S; Toda T; Tsuji S; Iwata A
    Brain Res; 2018 Oct; 1697():59-66. PubMed ID: 29909202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-Generation RNA-Sequencing of Serum Small Extracellular Vesicles Discovers Potential Diagnostic Biomarkers for Dementia With Lewy Bodies.
    Rajkumar AP; Hye A; Lange J; Manesh YR; Ballard C; Fladby T; Aarsland D
    Am J Geriatr Psychiatry; 2021 Jun; 29(6):573-584. PubMed ID: 33160816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson's Disease.
    Marsal-García L; Urbizu A; Arnaldo L; Campdelacreu J; Vilas D; Ispierto L; Gascón-Bayarri J; Reñé R; Álvarez R; Beyer K
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration.
    Noori A; Mezlini AM; Hyman BT; Serrano-Pozo A; Das S
    Neurobiol Dis; 2021 Feb; 149():105225. PubMed ID: 33347974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer's disease and Parkinson's disease: a large-scale multi-trait association analysis.
    Guo P; Gong W; Li Y; Liu L; Yan R; Wang Y; Zhang Y; Yuan Z
    BMC Med; 2022 Jun; 20(1):214. PubMed ID: 35729600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology of Lewy body diseases.
    Beyer K; Domingo-Sàbat M; Ariza A
    Int J Mol Sci; 2009 Mar; 10(3):724-45. PubMed ID: 19399218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of Inflammation in Lewy Body Dementia: A Systematic Scoping Review.
    Loveland PM; Yu JJ; Churilov L; Yassi N; Watson R
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
    Beyer K; Domingo-Sàbat M; Santos C; Tolosa E; Ferrer I; Ariza A
    Brain; 2010 Dec; 133(Pt 12):3724-33. PubMed ID: 20959308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.